EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activin A Secreted by Cancer-Associated Fibroblasts Reduces the Sensitivity of Breast Cancer Cells to Ixazomib via Inhibition of Proteasome Activity

Shuaiming Geng, Siyao Liu, He Liu, Siao Wang, Yichen Niu, Jing Gao, Yong Meng iD, Mingqing Gao

Biomolecules · 2025

DOI: 10.3390/biom15091318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Shuaiming Geng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Northwest University, Xi'an 710069, China. Hauptthemen laut MEDLINE: Boron Compounds, Glycine, Breast Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ming-qing Gao, Yong Meng, Research start-up foundation in Northwest University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) remains a leading cause of cancer-related mortality among women globally, and the role of cancer-associated fibroblasts (CAFs) in promoting BC progression is well established. Ixazomib, a proteasome inhibitor approved for the treatment of multiple myeloma, has demonstrated therapeutic potential in BC in preclinical trials. However, whether its efficacy is influenced by the tumor microenvironment, particularly CAFs, remains unclear. This study aims to investigate the role of CAFs with high expression of Activin A (encoded by INHBA) in modulating the sensitivity of BC cells to ixazomib. We demonstrate that ixazomib exhibited significant cytotoxicity in BC cells, but high-INHBA CAFs compromise ixazomib cytotoxicity through ERK-mediated proteasome suppression, reversible by Activin A antagonism. Additionally, the overexpression of INHBA in fibroblasts reduces the efficacy of ixazomib in xenograft models. Clinical data analysis revealed that high INHBA expression is associated with poor prognosis in BC patients and reduced immune cell infiltration. These findings suggest that targeting INHBA in CAFs could enhance the therapeutic efficacy of ixazomib in BC, particularly in patients with low INHBA expression. This study provides novel insights into the role of CAFs in drug resistance and identifies INHBA as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron CompoundsGlycineBreast NeoplasmsCancer-Associated FibroblastsProteasome Endopeptidase ComplexProteasome InhibitorsActivinsHumansFemaleAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysTumor MicroenvironmentAntineoplastic AgentsDrug Resistance, NeoplasmMice, NudeCell Proliferation

Stichwörter der Autor:innen

INHBA/Activin Abreast cancercancer-associated fibroblastsdrug resistanceixazomib

Substanzen

ixazomibBoron CompoundsGlycineProteasome Endopeptidase ComplexProteasome InhibitorsActivinsactivin AAntineoplastic Agents

Autor:innen und Institutionen

  • School of Medicine, Northwest University, Xi'an 710069, China.
  • College of Life Sciences, Northwest University, Xi'an 710069, China.
  • Department of Oncology Surgery, Xi'an No. 3 Hospital-The Affiliated Hospital of Northwest University, Xi'an 710018, China.

ORCID-Profile: Yong Meng

Förderung

  • Ming-qing Gao
  • Yong Meng
  • Research start-up foundation in Northwest University
  • Cultivation Project for National Natural Science Foundation of Xi’an No. 3 Hospital, the Affiliated Hospital of Northwest University

Zitieren

APA

Geng, S., Liu, S., Liu, H., Wang, S., Niu, Y., Gao, J., Meng, Y., & Gao, M. (2025). Activin A Secreted by Cancer-Associated Fibroblasts Reduces the Sensitivity of Breast Cancer Cells to Ixazomib via Inhibition of Proteasome Activity. Biomolecules. https://doi.org/10.3390/biom15091318

Vancouver

Geng S, Liu S, Liu H, Wang S, Niu Y, Gao J, et al. Activin A Secreted by Cancer-Associated Fibroblasts Reduces the Sensitivity of Breast Cancer Cells to Ixazomib via Inhibition of Proteasome Activity. Biomolecules. 2025. doi:10.3390/biom15091318

BibTeX
@article{Geng2025,
  author = {Geng, Shuaiming and Liu, Siyao and Liu, He and Wang, Siao and Niu, Yichen and Gao, Jing and Meng, Yong and Gao, Mingqing},
  title = {Activin A Secreted by Cancer-Associated Fibroblasts Reduces the Sensitivity of Breast Cancer Cells to Ixazomib via Inhibition of Proteasome Activity},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15091318}
}
Kostenlos starten →